Effects of SGLT-2 inhibitors and GLP-1 receptor agonists on liver function in patients with non-alcoholic fatty liver disease and type 2 diabetes - Top-Institutions - MDSpire

Effects of SGLT-2 inhibitors and GLP-1 receptor agonists on liver function in patients with non-alcoholic fatty liver disease and type 2 diabetes

  • By

  • Wancheng Guo

  • Wenhe Li

  • Xianlin Li

  • Wen Shi

  • Yan Yan

  • Ting Yan

  • Jie Zhou

  • Yujie Huang

  • June 3, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Hepatology

  • #2

    UC San Diego Health
    UC San Diego Health

    La Jolla, California

    Key Differentiators

    • Endocrinology
    • Gastroenterology

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Endocrinology
    • Hepatology

Original Source(s)

Effects of SGLT-2 inhibitors and GLP-1 receptor agonists on liver function in patients with non-alcoholic fatty liver disease and type 2 diabetes

  • by Wancheng Guo, Wenhe Li, Xianlin Li, Wen Shi, Yan Yan, Ting Yan, Jie Zhou, Yujie Huang

  • June 3, 2026

Related Content

Cardiovascular–kidney–metabolic syndrome and mortality in a prospective UK cohort study

Insights on Improving Health Insurance Literacy in Diabetes

Lifetime prevention must start before conception